Is nuclear , compared with combined nuclear and cytoplasmic expression of maspin , linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I , improved survival?
(N) maspin selects lung adenocarcinomas with distinct molecular and clinical features, supporting the hypothesis that its tumour inhibitor properties may be linked to its nuclear localization.
Lower BMI was independently associated with increased long-term all-cause, as well as cardiac, mortality in patients with HF encountered in routine clinical practice in Japan.